Events9th International Electronic Conference on Medicinal Chemistry
Published
with-doi10.3390/ECMC2023-15713 (registering DOI)
This submission belongs to the session S5. Natural Products and Biopharmaceuticals of the event 9th International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2023
Academic Editor
author-avatarMaria Emília Sousa
Citation
Ivanna Prylutska, Zenoviy Tkachuk, Alteration of relative mRNA levels of Tlr-dependent genes in melanoma B16 cells by oligoribonucleotides-D-mannitol treatment, in Proceedings of 9th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2023, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2023-15713
Share
Email
Facebook
Twitter
LinkedIn

Alteration of relative mRNA levels of Tlr-dependent genes in melanoma B16 cells by oligoribonucleotides-D-mannitol treatment

image
1. Institute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine, Ukraine
2. Institute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine
Abstract

Natural oligoribonucleotides in complex with D-mannitol (ORN-D-M) exhibit a range of biological activities, including antiviral and antioxidant effects. In previous investigations, we observed that ORN-D-M demonstrated cytotoxicity on various malignant cell lines in a dose- and time-dependent manner. The aim of the current work was to determine the possible mechanisms of melanoma B16 cell inhibition by ORN-D-M. For this investigation, we examined the relative mRNA expression of various RNA sensors and their downstream-regulated pathways after ORN-D-M treatment of mouse melanoma B16 cells.

It was shown that ORN-D-M caused overexpression of ss-, dsRNA receptors Tlr3, 7, 8, and Eif2ak; the inflammation-suppressive subunit Nfkb1; and IFN type 1. Along with this, downregulation was observed in the mRNA expression of inflammatory cytokines Tnfa and Il1b, which are known as promoters of tumor progression. The ORN-D-M treatment affected apoptosis regulatory molecules, significantly decreasing the relative mRNA level of the antiapoptotic Bcl-2, and slightly increasing proapoptotic Bax.

Therefore, ORN-D-M can be an agonist to Tlr and Eif2ak receptors in melanoma cancer cells, causing the activation of proapoptotic signals through the Nfkb1-dependent pathway.

Keywords
ORN-D-M
RNA receptors
alteration of relative mRNA levels
Manuscript
Bioavailability Amelioration of Zaleplon by developing self emulsifying drug delivery systems
Design, Synthesis of New 1,3,5-tris[(4-(Substituted-aminomethyl)phenoxy)methyl]benzene derivatives and Evaluation of their Antimalarial Activity